1. Show article details.

    GLOBAL MARKETS-Wall Street rallies as bond sell-off pauses, oil gains

    Reuters – 11:53 AM ET 01/20/2022

    * Stocks on Wall Street and in Europe gain. * Crude oil prices initially slip then regain 2014 highs. * China stocks gain after cut in benchmark mortgage rates. * Risk of Russia-Ukraine flare up could weigh on markets -ING. By Herbert Lash and Huw Jones.

  2. Show article details.

    BRIEF-Marinhealth And Optum Launch New Strategic Relationship To Streamline Administrative Functions And Improve Patient Experience In Marin County, California

    Reuters – 8:23 AM ET 01/20/2022

    MarinHealth: * MARINHEALTH AND OPTUM LAUNCH NEW STRATEGIC RELATIONSHIP TO STREAMLINE ADMINISTRATIVE FUNCTIONS AND IMPROVE PATIENT EXPERIENCE IN MARIN COUNTY, CALIFORNIA. * MARINHEALTH - OPTUM WILL PROVIDE CRITICAL SUPPLY CHAIN AND REVENUE CYCLE SERVICES FOR MEDICAL CENTER.

  3. Show article details.

    GLOBAL MARKETS-Wall Street headed higher as tech investors lick their wounds

    Reuters – 8:08 AM ET 01/20/2022

    * Rise in U.S. stock futures push Europe into the black. * Crude oil prices slip from 2014 highs. * Rise in U.S. Treasury yields stall. * China stocks gain after cut in benchmark mortgage rates. * Risk of Russia-Ukraine flare up could weigh on markets -ING. * Nasdaq enters correction territory but futures up. By Huw Jones.

  4. Show article details.

    MarinHealth and Optum Launch New Strategic Relationship to Streamline Administrative Functions and Improve the Patient Experience in Marin County, California

    Business Wire – 8:00 AM ET 01/20/2022

    Optum Will Provide Critical Supply Chain and Revenue Cycle Services for the Medical Center MarinHealth Medical Center and Optum today announced a strategic relationship to advance MarinHealth’s operational objectives and support MarinHealth’s continued commitment to providing high-quality, affordable, convenient and accessible care for North Bay residents. This press release features multimedia.

  5. Show article details.

    Microsoft-Activision deal gives merger speculators a new darling

    Reuters – 6:05 AM ET 01/20/2022

    - Hedge funds that earn returns speculating on precarious acquisitions were handed a gift this week when Microsoft Corp (MSFT) agreed to buy "Call of Duty" maker Activision Blizzard (ATVI) for $68.7 billion in cash. The transaction will require antitrust approval in the United States as well as other major jurisdictions including the European Union and China.

  6. Show article details.

    Microsoft-Activision deal gives merger speculators a new darling

    Reuters – 6:00 AM ET 01/20/2022

    Hedge funds that earn returns speculating on precarious acquisitions were handed a gift this week when Microsoft Corp (MSFT) agreed to buy "Call of Duty" maker Activision Blizzard (ATVI) for $68.7 billion in cash. The transaction will require antitrust approval in the United States as well as other major jurisdictions including the European Union and China.

  7. Show article details.

    Sesame Workshop Launches New Resources to Help Children and Families Build a Lifelong Foundation of Resilience

    Business Wire – 6:00 AM ET 01/20/2022

    With support from UnitedHealthcare, free online courses for providers and digital storybooks for children build upon Sesame Workshop’s ongoing commitment to building happy and healthy communities Sesame Workshop, the nonprofit behind Sesame Street, is launching new bilingual resources, made possible by UnitedHealthcare, to help children build resilience and thrive in their communities.

  8. Show article details.

    GLOBAL MARKETS-Stocks slide on inflation concerns as oil prices rise further

    Reuters – 4:35 PM ET 01/19/2022

    * Investors brace for tighter monetary policy. * Oil hits fresh 7-year high after Turkey pipeline outage. * Nasdaq confirms a correction as Wall Street slides. * Bond yields slip after big jump prior session. By Herbert Lash and Lawrence White.

  9. Show article details.

    US STOCKS-Wall Street selloff deepens, Nasdaq confirms correction

    Reuters – 3:38 PM ET 01/19/2022

    By Lewis Krauskopf, Shreyashi Sanyal and Bansari Mayur Kamdar. Wall Street fell on Wednesday, with the tech-heavy Nasdaq confirming a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy. The Nasdaq ended down over 10% from its Nov 19 closing record high.

  10. Show article details.

    US STOCKS-S&P 500, Nasdaq edge higher after upbeat earnings reports

    Reuters – 2:13 PM ET 01/19/2022

    * Nasdaq briefly falls over 10% from record closing high. * BofA, Morgan Stanley (MS) wrap up bank earnings on upbeat note. * Procter & Gamble (PG) gains after raising outlook. * Dow down 0.1%, S&P up 0.08%, Nasdaq up 0.22% By Lewis Krauskopf, Shreyashi Sanyal and Bansari Mayur Kamdar.

  11. Show article details.

    US STOCKS-S&P 500, Dow up on earnings lift, Nasdaq off session low

    Reuters – 12:58 PM ET 01/19/2022

    * UnitedHealth (UNH) rises as Q4 profit beats estimates. * BofA, Morgan Stanley (MS) wrap up bank earnings on upbeat note. * P&G gains after raising outlook, beating Q2 rev estimates. * Nasdaq briefly falls over 10% from record closing high. * Indexes rise: Dow 0.27%, S&P 0.25%, Nasdaq 0.16% By Shreyashi Sanyal and Bansari Mayur Kamdar.

  12. Show article details.

    GLOBAL MARKETS-Stocks slip on inflation concerns as oil prices rise further

    Reuters – 12:08 PM ET 01/19/2022

    * Investors brace for tighter monetary policy. * Oil hits fresh 7-year high after Turkey pipeline outage. * Wall Street can't hold initial gains, Europe pares gains. * Value shares trend higher as growth stocks slip. By Herbert Lash and Lawrence White.

  13. Show article details.

    US STOCKS-Wall St rises on earnings boost; Big Tech bounces back

    Reuters – 10:01 AM ET 01/19/2022

    * UnitedHealth (UNH) rises as Q4 profit beats estimates. * BofA, Morgan Stanley (MS) wrap up bank earnings on upbeat note. * P&G gains after raising outlook, beating Q2 rev estimates. * Indexes rise: Dow 0.39%, S&P 0.61%, Nasdaq 0.70% By Shreyashi Sanyal and Bansari Mayur Kamdar.

  14. Show article details.

    US STOCKS-Wall St set to open higher on earnings boost, Big Tech bounces back

    Reuters – 9:11 AM ET 01/19/2022

    * UnitedHealth (UNH) rises as Q4 profit beats estimates. * BofA, Morgan Stanley (MS) wrap up bank earnings on upbeat note. * P&G gains on raising sales outlook, tops Q2 rev estimates. * Futures up: Dow 0.26%, S&P 0.38%, Nasdaq 0.56% By Shreyashi Sanyal.

  15. Show article details.

    GLOBAL MARKETS-Stocks steady, bond yields jump as inflation fears crescendo

    Reuters – 8:37 AM ET 01/19/2022

    * Investors brace for tighter monetary policy. * Oil hits fresh 7-year high after Turkey pipeline outage. * Rate-sensitive tech stocks lead stock market decline. By Lawrence White and Daniel Leussink.

  16. Show article details.

    US STOCKS-Futures gain as UnitedHealth, BofA rise on results

    Reuters – 7:32 AM ET 01/19/2022

    * Futures up: Dow 0.23%, S&P 0.29%, Nasdaq 0.44% By Shreyashi Sanyal. Upbeat results from UnitedHealth (UNH) and Bank of America (BAC) pushed U.S. stock index futures higher on Wednesday, partially righting a wobbly start to the fourth-quarter earnings reporting season, while Big Tech stocks also looked set to make a comeback.

  17. Show article details.

    UnitedHealth says Omicron-driven cost impact cushioned by healthcare deferrals

    Reuters – 6:20 AM ET 01/19/2022

    UnitedHealth Group Inc (UNH) on Wednesday said added costs of testing and treatment related to the recent surge in COVID-19 cases are being offset by postponements of non-urgent healthcare procedures, and the health insurer maintained its 2022 profit forecast.

  18. Show article details.

    UnitedHealth says Omicron-driven cost impact cushioned by healthcare deferrals

    Reuters – 6:02 AM ET 01/19/2022

    -UnitedHealth Group Inc (UNH) on Wednesday said added costs of testing and treatment related to the recent surge in COVID-19 cases are being offset by postponements of non-urgent healthcare procedures, and the health insurer maintained its 2022 profit forecast.

  19. Show article details.

    Health insurer UnitedHealth profit rises 84% on Optum strength

    Reuters – 6:00 AM ET 01/19/2022

    UnitedHealth Group Inc (UNH) said on Wednesday its quarterly profit rose 84%, helped partly by growth in its Optum unit that includes its drug benefits management business. Net earnings attributable to shareholders rose to $4.07 billion, or $4.26 per share, in the fourth quarter ended Dec. 31, from $2.21 billion, or $2.30 per share, a year earlier.

  20. Show article details.

    BRIEF-Unitedhealth Group Inc Reports Full Year And Q4 Net Earnings of $18.08 And $4.26 Per Share

    Reuters – 5:59 AM ET 01/19/2022

    UnitedHealth Group Inc (UNH): * FULL YEAR AND Q4 NET EARNINGS WERE $18.08 AND $4.26 PER SHARE. * FULL YEAR AND Q4 ADJUSTED NET EARNINGS WERE $19.02 AND $4.48 PER SHARE. * QTRLY REVENUES $73.7 BILLION VERSUS $65.5 BILLION. * AFFIRMED 2022 GROWTH AND PERFORMANCE OBJECTIVES ESTABLISHED AT ITS NOVEMBER 30, 2021 INVESTOR CONFERENCE.

Page:

Today's and Upcoming Events

  • Apr
    13

    UNH to announce Q1 earnings (Unconfirmed)

Past Events (last 90 days)

  • Jan
    19

    UNH announced Q4 earnings.

  • Dec
    03

    UNH ex-Dividend for $1.45 on 12/03/2021

    • Announce Date: 11/05/2021
    • Record Date: 12/06/2021
    • Pay Date: 12/14/2021
Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.